West Pharmaceutical Services, Inc. (WST)

NYSE | Industrials | Injectable drug packaging and delivery
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.
Free
No email, no account, no signup.
Pulling latest news for West Pharmaceutical Services, Inc.…
Bull
Bear
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – $4.99 $1.25
Order analysis – $4.99 $1.25

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NYSE
Type
Industrials
Sector
Injectable drug packaging and delivery
Market Cap
$21.9B

Market sentiment

Sentiment is neutrally stable: attention has shifted from product/growth narratives to cybersecurity and recovery, but full operational restoration and unchanged guidance have contained negativity.

Why HOLD ?

The incident increases operational risk (potential remediation costs, regulatory exposure, and customer trust impacts), but the rapid recovery and reiterated guidance support waiting for the Q2 print to confirm any margin/cost effects.
  • Hold/wait: maintain the position and reassess after Q2 results and any disclosures on incident costs, insurance recoveries, and customer impact.
We're already tracking West Pharmaceutical Services, Inc. — here are the latest events we've registered

Recent News

  • West posted strong Q1 2026 results and raised full-year guidance on robust demand (including GLP-1-related components). It then disclosed a material cyberattack (detected May 4) involving data exfiltration and system encryption, but the latest 8-K/A states core systems, manufacturing, and global shipping are fully restored and management does not expect a material impact to Q2 or full-year 2026 guidance.
Want to know how this news affects West Pharmaceutical Services, Inc.? Order the analysis.
Order analysis – $4.99 $1.25

Catalysts

Follow-on disclosures on cyber incident costs/liability

Unlock full catalyst analysis →
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Sources: news, filings, market data, and investor forums
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of West Pharmaceutical Services, Inc. will be delivered in the same format.
Order analysis – $4.99 $1.25
Not satisfied? Get your money back within 7 days — no questions asked.
West Pharmaceutical Services, Inc. (WST)
Fresh analysis on demand
Buy express analysis – $4.99 $1.25
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.